Reduced Nicotine Cigarettes in Smokers With and Without Alcohol Use Disorder
RedNic
1 other identifier
interventional
47
1 country
1
Brief Summary
The proposed research will investigate whether smokers with vs. without current at-risk alcohol drinking (ARD) respond to reduced nicotine cigarettes by increasing their alcohol consumption or smoke exposure, thereby diminishing the hypothesized public health benefit of these new products.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Nov 2017
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 7, 2016
CompletedFirst Posted
Study publicly available on registry
December 13, 2016
CompletedStudy Start
First participant enrolled
November 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 21, 2021
CompletedSeptember 29, 2021
September 1, 2021
3.4 years
December 7, 2016
September 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Alcohol drinks per day
7 days
Secondary Outcomes (3)
Toxicant exposure
7 days
Subjective acceptability
7 days
Smoking compensation
7 days
Study Arms (2)
Reduced Nicotine Cigarette - Moderate
EXPERIMENTALNicotine Research Cigarette Drug Supply Program Category Codes NRC600 and NRC601 (menthol); each cigarette contains 0.8mg nicotine; participants will be instructed to smoke these cigarettes according to their usual smoking patterns
Reduced Nicotine Cigarette - Low
EXPERIMENTALNicotine Research Cigarette Drug Supply Program Category Codes NRC102 and NRC103 (menthol); each cigarette contains 0.03mg nicotine; participants will be instructed to smoke these cigarettes according to their usual smoking patterns
Interventions
Participants will be assigned to undergo two experimental conditions (i.e., exclusive smoking of RNC Low or Moderate in their home environment for 7 days) in a double-blind, randomized, crossover design. The two experimental conditions will be separated by a 7-day period of return to smoking of participants' own brand of cigarette.
Eligibility Criteria
You may qualify if:
- Ages 21-65;
- Smokes ≥ 10 cigarettes/day for ≥ 2 years;
- Has no immediate plans to quit drinking or smoking; and
- Sufficient understanding of informed consent form and study procedures.
You may not qualify if:
- Has or is at-risk of serious alcohol-related consequences, defined as any of the following:
- Meets DSM-5 criteria for current alcohol use disorder with the presence of 6 or more symptoms (i.e., current severity of severe)
- Has a Clinical Institute Withdrawal Assessment scale score of ≥8,
- Self-report of history of seizures, delirium, or hallucinations during alcohol withdrawal;
- Self-report of drinking to avoid withdrawal symptoms, or
- Self-report of a history of alcohol withdrawal treatment.
- Women if pregnant, lactating, or not using a reliable form of birth control;
- Has current serious psychiatric disorder;
- Has DSM-5 current severe substance use disorder, other than nicotine;
- Has current use of smokeless tobacco, pipes, cigars, e-cigarettes, or nicotine replacement products;
- Displays clinically evident intoxication on any study visit, confirmed by breathalyzer test (breath alcohol level (BAL)\>0.02 mg%);
- Has difficulties with blood draws or poor venous access; or
- Has significant smoking-related disease (by history).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Battelle Memorial Institute
Baltimore, Maryland, 21209, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 7, 2016
First Posted
December 13, 2016
Study Start
November 14, 2017
Primary Completion
April 21, 2021
Study Completion
April 21, 2021
Last Updated
September 29, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share